FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2978743145> ?p ?o ?g. }

• W2978743145 endingPage "S483" @default.
• W2978743145 startingPage "S482" @default.
• W2978743145 abstract "Purpose: Crohn's Disease Activity Index (CDAI) and C-reactive protein (CRP) are widely used parameters to evaluate treatment effect in Crohn's disease. Anti-Mycobacterium avium paratuberculosis (Anti-MAP) therapy comprising rifabutin, clarithromycin and clofazimine has been shown to be effective in achieving remission in 66% of patients at 16 weeks 1. The time-course responses of individual CDAI components and CRP levels in response to anti-MAP therapy are unknown. Aim: To observe the time-course responses of CDAI components and CRP levels during anti-MAP therapy in moderate-to-severe Crohn's disease. Methods: Fifteen patients with active moderate-to-severe Crohn's disease failing other treatments were commenced on Anti-MAP therapy (ramp-up dosing), with CDAI and CRP measured at baseline and during treatment whilst on concomitant medications including mesalazine, corticosteroids and/or immunosuppressives. Analysis of CRP levels and CDAI variables were performed at each follow-up visit to determine which disease-related variables responded the greatest during therapy. Results: A significant decrease in CDAI scores and CRP levels from baseline to Week 51 was observed. 100% (15/15) of patients responded to anti-MAP therapy and experienced a decrease of 70 points from their baseline CDAI score (mean 354.5 ±161.9), with a mean response time of 6.8 ± 4.8 weeks. 12/15 patients (80%) experienced a decrease of 100 points from their baseline CDAI score and a response time of 7.0 ± 5.2 weeks. A decrease in CRP levels from a baseline level of 48 ± 75 mg/L to 12.02 ± 16 and 15.7±18.7 mg/L was observed in each group respectively whilst on anti-MAP therapy. All patients achieved remission at 16 ± 4.9 weeks, defined as a CDAI score < 150. In 13 of the 15 patients who experienced a CDAI of < 150 throughout treatment (26-51 wks), the time to achieve remission was 18.3 ± 9.2 weeks. A reduction in the number of liquid motions occurred from a mean baseline score of 88.7 ± 87.5 to a mean final score of 14.9 ±18.8, a reduction of 83.2%. A reduction in abdominal pain severity occurred from a mean baseline score of 67 ± 36.9 to a mean final score of 8 ± 14.1, an 88.0% reduction. An improvement in general well-being also occurred from a mean baseline score of 127.4 ± 60.9 to 17.3 ± 23.5, an improvement of 86.4%. Conclusion: Anti-MAP therapy resulted in a rapid and sustained decrease in CDAI scores, with a paralleled decrease in CRP levels. The first 3 CDAI variables comprising liquid stool, abdominal pain and general well-being showed the greatest response during therapy. 1. Selby W, Pavli P, Crotty B, et al. Gastroenterology 2007;132:2313-2319. Disclosure: Prof T. Borody - Director, Proprietary owner - Centre for Digestive Diseases, Stockholder - Giaconda Ltd. Jordana Campbell - Employee of the Centre for Digestive Diseases. Margaux Torres - Employee of the Centre for Digestive Diseases. Lauren A. Hills - Employee of the Centre for Digestive Diseases. Sahisha Ketheeswaran - Employee of the Centre for Digestive Diseases. Sharyn Leis- Employee of the Centre for Digestive Diseases. Gerald Pang - Consultant for the Centre for Digestive Diseases." @default.
• W2978743145 created "2019-10-10" @default.
• W2978743145 creator A5015123219 @default.
• W2978743145 creator A5028932625 @default.
• W2978743145 creator A5059070507 @default.
• W2978743145 creator A5066408879 @default.
• W2978743145 creator A5069535588 @default.
• W2978743145 creator A5075505238 @default.
• W2978743145 creator A5082358450 @default.
• W2978743145 date "2009-10-01" @default.
• W2978743145 modified "2023-09-25" @default.
• W2978743145 title "Changes in Crohnʼs Disease Activity Index and C-reactive Protein Levels During Anti-MAP Therapy" @default.
• W2978743145 doi "https://doi.org/10.14309/00000434-200910003-01293" @default.
• W2978743145 hasPublicationYear "2009" @default.
• W2978743145 type Work @default.
• W2978743145 sameAs 2978743145 @default.
• W2978743145 citedByCount "0" @default.
• W2978743145 crossrefType "journal-article" @default.
• W2978743145 hasAuthorship W2978743145A5015123219 @default.
• W2978743145 hasAuthorship W2978743145A5028932625 @default.
• W2978743145 hasAuthorship W2978743145A5059070507 @default.
• W2978743145 hasAuthorship W2978743145A5066408879 @default.
• W2978743145 hasAuthorship W2978743145A5069535588 @default.
• W2978743145 hasAuthorship W2978743145A5075505238 @default.
• W2978743145 hasAuthorship W2978743145A5082358450 @default.
• W2978743145 hasConcept C126322002 @default.
• W2978743145 hasConcept C2776409635 @default.
• W2978743145 hasConcept C2776914184 @default.
• W2978743145 hasConcept C2776962512 @default.
• W2978743145 hasConcept C2778260677 @default.
• W2978743145 hasConcept C2779134260 @default.
• W2978743145 hasConcept C2779174533 @default.
• W2978743145 hasConcept C2779280984 @default.
• W2978743145 hasConcept C2779384505 @default.
• W2978743145 hasConcept C2781195455 @default.
• W2978743145 hasConcept C71924100 @default.
• W2978743145 hasConcept C90924648 @default.
• W2978743145 hasConceptScore W2978743145C126322002 @default.
• W2978743145 hasConceptScore W2978743145C2776409635 @default.
• W2978743145 hasConceptScore W2978743145C2776914184 @default.
• W2978743145 hasConceptScore W2978743145C2776962512 @default.
• W2978743145 hasConceptScore W2978743145C2778260677 @default.
• W2978743145 hasConceptScore W2978743145C2779134260 @default.
• W2978743145 hasConceptScore W2978743145C2779174533 @default.
• W2978743145 hasConceptScore W2978743145C2779280984 @default.
• W2978743145 hasConceptScore W2978743145C2779384505 @default.
• W2978743145 hasConceptScore W2978743145C2781195455 @default.
• W2978743145 hasConceptScore W2978743145C71924100 @default.
• W2978743145 hasConceptScore W2978743145C90924648 @default.
• W2978743145 hasLocation W29787431451 @default.
• W2978743145 hasOpenAccess W2978743145 @default.
• W2978743145 hasPrimaryLocation W29787431451 @default.
• W2978743145 hasRelatedWork W149565788 @default.
• W2978743145 hasRelatedWork W1978993934 @default.
• W2978743145 hasRelatedWork W2029403749 @default.
• W2978743145 hasRelatedWork W2084197120 @default.
• W2978743145 hasRelatedWork W2119817537 @default.
• W2978743145 hasRelatedWork W2166458195 @default.
• W2978743145 hasRelatedWork W2547337719 @default.
• W2978743145 hasRelatedWork W260976906 @default.
• W2978743145 hasRelatedWork W4226043652 @default.
• W2978743145 hasRelatedWork W52633626 @default.
• W2978743145 hasVolume "104" @default.
• W2978743145 isParatext "false" @default.
• W2978743145 isRetracted "false" @default.
• W2978743145 magId "2978743145" @default.
• W2978743145 workType "article" @default.